Merck PE Ratio 2010-2024 | MKKGY
Current and historical p/e ratio for Merck (MKKGY) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Merck PE ratio as of October 29, 2024 is 23.25.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Merck PE Ratio Historical Data |
Date |
Stock Price |
TTM Net EPS |
PE Ratio |
|
0.00 |
|
nan |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$21.306B |
$22.719B |
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|